<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>

COPY SCRIPT

For further information contact us at helpdesk@openaire.eu

Cerebrovascular Accidents in Ranibizumab

descriptionPublicationkeyboard_double_arrow_right Article 01 Feb 2009 English Publisher:Elsevier BVJournal:Ophthalmology, volume 116, pages 362-3,620 (issn: 0161-6420,

Authors: Takuhiro Yamaguchi; Yasuhiro Tamaki; Yasuo Yanagi; Takashi Ueta;

doi: 10.1016/j.ophtha.2008.09.046

pmid: 19187826

Cerebrovascular Accidents in Ranibizumab

- Summary
- Subjects
- Metrics

No summary information available

Keywords

Clinical Trials as Topic, Databases, Factual, Incidence, Myocardial Infarction, Antibodies, Monoclonal, Angiogenesis Inhibitors, Antibodies, Monoclonal, Humanized, Injections, Stroke, Vitreous Body, Macular Degeneration, Risk Factors, Ranibizumab, Odds Ratio, Humans

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	110
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 10%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 1%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 1%